Pharmaceuticals: SCRUTINY CONTINUES ON DRUG REBATES
Feds want states to get tough on hot-button issue for drugmakers
If you haven't gotten the picture yet that Medicaid drug rebates are becoming a key issue in pharmaceutical-related health care fraud enforcement, it's time to wake up and smell the coffee.
The HHS Office of Inspector General is scouring state records nationwide to make sure Medicaid agencies are doing their job to secure the rebates - and it's calling on many states to do a better job.
The fact that the feds are so concerned with the issue is important for drug manufacturers, since the cost of...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: